Cross-Sectional Inverse Associations of Obesity and Fat Accumulation Indicators with Testosterone in Non-Diabetic Aging Men

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2018 Jun 13

PMID 29890654

Citations 11

Authors

Iwona Rotter

Aleksandra Ryl

Katarzyna Grzesiak

Aleksandra Szylinska

Wioletta Pawlukowska

Anna Lubkowska

Olimpia Sipak-Szmigiel

Krzysztof Pabisiak

Maria Laszczynska

Affiliations

Soon will be listed here.

Abstract

: The aim of the study was to show which of the adipose tissue accumulation indicators correlate with testosterone disorders in non-diabetic aging men. : 455 non diabetic men, recruited at primary care facilities, aged 50⁻75 participated in the study. The participants underwent anthropometric measurement and ELISA determination of total testosterone (TT), estradiol (E₂), dehydroepiandrosterone sulphate (DHEA-S), sex hormone binding protein (SHBG), and the determination of fasting glucose (FPG), high-density lipids cholesterol (HDL-Ch), and triacylglycerols (TAG) in serum. The following indicators were calculated: body mass index (BMI), waist-to-hip ratio (WHR), lipid accumulation product (LAP), and visceral adiposity index (VAI). : Men with testosterone deficiency syndrome (TDS) differed in each of the assessed obesity indices from those without TDS. All of the studied parameters correlated significantly negatively with TT concentration in blood serum, with VAI being the strongest predictor of TDS. It was shown that the threshold value at which the risk of TDS increased was 28.41 kg/m² for BMI, 1.58 for VAI, 104 cm for WC, and 37.01 for LAP. : Indicators of fat accumulation that take into account biochemical parameters in assessing lipid metabolism are better markers of actual body fat deposition than indicators based solely on anthropometric measurements. Among them, VAI seems the most suitable biomarker of TDS in non-diabetic aging men.

Citing Articles

Establishment and Evaluation of a Noninvasive Metabolism-Related Fatty Liver Screening and Dynamic Monitoring Model: Cross-Sectional Study.

Ni J, Huang Y, Xiang Q, Zheng Q, Xu X, Qin Z Interact J Med Res. 2024; 13:e56035.

PMID: 39172506 PMC: 11377904. DOI: 10.2196/56035.

Muscle Strength and Male Sexual Function.

Viken A, Siiak S, Schlunssen V, Thorarinsdottir E, Skulstad S, Gyawali S J Clin Med. 2024; 13(2).

PMID: 38256560 PMC: 10816204. DOI: 10.3390/jcm13020426.

The Fatty Liver Index, the Strongest Risk Factor for Low Testosterone Level.

Liu L, Li M, Chen P, Li Y, Song Q, Han J Obes Facts. 2023; 16(6):588-597.

PMID: 37797596 PMC: 10697743. DOI: 10.1159/000533962.

The Impact of Visceral Adiposity on Testosterone Levels in American Adult Men: A Cross-Sectional Analysis.

Su M, Wei H, Chen L, Guan Y, Dong W, Zhao M Med Sci Monit. 2023; 29:e941394.

PMID: 37634076 PMC: 10469406. DOI: 10.12659/MSM.941394.

Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA.

Pavey H, Polkey M, Bolton C, Cheriyan J, Mceniery C, Wilkinson I BMJ Open Respir Res. 2023; 10(1).

PMID: 37316306 PMC: 10277522. DOI: 10.1136/bmjresp-2022-001601.

References

Blaya R, Thomaz L, Guilhermano F, Paludo A, Rhoden L, Halmenschlager G . Total testosterone levels are correlated to metabolic syndrome components. Aging Male. 2016; 19(2):85-9. DOI: 10.3109/13685538.2016.1154523. View

Cohen P . The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt--a major factor in the genesis of morbid obesity. Med Hypotheses. 1999; 52(1):49-51. DOI: 10.1054/mehy.1997.0624. View

Morley J . Androgens and aging. Maturitas. 2001; 38(1):61-71; discussion 71-3. DOI: 10.1016/s0378-5122(00)00192-4. View

Bergman R, Stefanovski D, Buchanan T, Sumner A, Reynolds J, Sebring N . A better index of body adiposity. Obesity (Silver Spring). 2011; 19(5):1083-9. PMC: 3275633. DOI: 10.1038/oby.2011.38. View

Kahn H . The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005; 5:26. PMC: 1236917. DOI: 10.1186/1471-2261-5-26. View

Shamim M, Ali Khan F, Arshad R . Association between serum total testosterone and Body Mass Index in middle aged healthy men. Pak J Med Sci. 2015; 31(2):355-9. PMC: 4476341. DOI: 10.12669/pjms.312.6130. View

Kelly D, Jones T . Testosterone: a vascular hormone in health and disease. J Endocrinol. 2013; 217(3):R47-71. DOI: 10.1530/JOE-12-0582. View

Seyfart T, Friedrich N, Kische H, Bulow R, Wallaschofski H, Volzke H . Association of sex hormones with physical, laboratory, and imaging markers of anthropometry in men and women from the general population. PLoS One. 2018; 13(1):e0189042. PMC: 5764233. DOI: 10.1371/journal.pone.0189042. View

Gapstur S, Kopp P, Gann P, Chiu B, Colangelo L, Liu K . Changes in BMI modulate age-associated changes in sex hormone binding globulin and total testosterone, but not bioavailable testosterone in young adult men: the CARDIA Male Hormone Study. Int J Obes (Lond). 2006; 31(4):685-91. DOI: 10.1038/sj.ijo.0803465. View

10.

Kim C, Dabelea D, Kalyani R, Christophi C, Bray G, Pi-Sunyer X . Changes in Visceral Adiposity, Subcutaneous Adiposity, and Sex Hormones in the Diabetes Prevention Program. J Clin Endocrinol Metab. 2017; 102(9):3381-3389. PMC: 5587076. DOI: 10.1210/jc.2017-00967. View

11.

Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F . Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2010; 8(1):272-83. DOI: 10.1111/j.1743-6109.2010.01991.x. View

12.

Wang N, Zhai H, Han B, Li Q, Chen Y, Chen Y . Visceral fat dysfunction is positively associated with hypogonadism in Chinese men. Sci Rep. 2016; 6:19844. PMC: 4726157. DOI: 10.1038/srep19844. View

13.

Kelly D, Jones T . Testosterone and obesity. Obes Rev. 2015; 16(7):581-606. DOI: 10.1111/obr.12282. View

14.

Jastrzebska S, Walczak-Jedrzejowska R, Kramek E, Marchlewska K, Oszukowska E, Filipiak E . Relationship between sexual function, body mass index and levels of sex steroid hormones in young men. Endokrynol Pol. 2014; 65(3):203-9. DOI: 10.5603/EP.2014.0028. View

15.

Isidori A, Caprio M, Strollo F, Moretti C, Frajese G, Isidori A . Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab. 1999; 84(10):3673-80. DOI: 10.1210/jcem.84.10.6082. View

16.

Page S, Matsumoto A, Bremner W . DHEA and testosterone in the elderly. N Engl J Med. 2007; 356(6):635. DOI: 10.1056/NEJMc063190. View

17.

Hayes F, Seminara S, DeCruz S, Boepple P, Crowley Jr W . Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab. 2000; 85(9):3027-35. DOI: 10.1210/jcem.85.9.6795. View

18.

Maturana M, Moreira R, Spritzer P . Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women. Maturitas. 2011; 70(4):395-9. DOI: 10.1016/j.maturitas.2011.09.012. View

19.

Amato M, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M . Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33(4):920-2. PMC: 2845052. DOI: 10.2337/dc09-1825. View

20.

Roseweir A, Millar R . The role of kisspeptin in the control of gonadotrophin secretion. Hum Reprod Update. 2008; 15(2):203-12. DOI: 10.1093/humupd/dmn058. View